A61K 39/187
Hog cholera virus
A61K39/187 (Hog cholera virus) appears on 5 US grants and 7 published applications in this corpus.
Search patents in A61K- Granted patents
- 5
- Published applications
- 7
- Assignees
- 6
- Inventors
- 14
- Latest grant
- 4 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 2 |
| 2023 | 0 | 1 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
By publication year.
Recent patents
- African swine fever virus vaccine4 Nov 2025US 12,458,690 B2Stichting Wageningen Research
- Immunological adjuvant composition, preparation method and application thereof15 Oct 2024US 12,115,218 B2Luoyang Seiwei Biotechnologies Co., Ltd.
- Live attenuated classical swine fever vaccine based in genetic manipulation of a putative fusion peptide area in the virus structural glycoprotein E214 Nov 2017US 9,814,771 B2The United States of America as represented by the Secretary of Agriculture
- N-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine24 Feb 2015US 8,961,996 B2The United States of America as represented by the Secretary of Agriculture
- Classical swine fever virus virulence determinant and a novel classical swine fever vaccine19 Feb 2008US 7,332,170 B1The United States of America as represented by the Secretary of Agriculture
- Artificial promiscuous t helper cell epitopes as immune stimulators for synthetic peptide immunogens13 Jul 2023US 2023/0218748 A1United Biomedical, Inc.
- African swine fever virus vaccine17 Feb 2022US 2022/0047694 A1Stichting Wageningen Research
- Immunological adjuvant composition, preparation method and application thereof17 Feb 2022US 2022/0047699 A1Luoyang Seiwei Biotechnologies Co., Ltd.
- Compositions for improving vaccine safety and efficacy and methods of use thereof23 Dec 2021US 2021/0393696 A1
- Live Attenuated Classical Swine Fever Vaccine Based in Genetic Manipulation of a Putative Fusion Peptide Area in the Virus Structural Glycoprotein E211 May 2017US 2017/0128563 A1The United States of America as represented by the Secretary of Agriculture
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.